Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

55.67
Delayed Data
As of 4:01pm ET
 +1.90 / +3.53%
Today’s Change
46.01
Today|||52-Week Range
77.12
-4.74%
Year-to-Date
Domino Effect of Falling Oil Prices: Cramer's 'Mad Money' Recap (Thursday 4/27/17)
7:04pm / TheStreet.com - Paid Partner Content
Rally Comes With Reasons for Concern
Apr 25 / TheStreet.com - Paid Partner Content
Cramer: When Oil Falls, These Dominoes Get Hit
7:04pm / TheStreet.com - Paid Partner Content
T. Rowe Price Keeps Buying Philip Morris, Wells Fargo, Others
Apr 24 / GuruFocus News - Paid Partner Content
Strong Sales for Opdivo and Eliquis Drive Bristol-Myers' Solid Q1
5:15pm / TheStreet.com - Paid Partner Content
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Apr 24 / Zacks.com - Paid Partner Content
PayPal Propels Nasdaq to New Record; Dow and S&P 500 Posts Small Gains
4:08pm / TheStreet.com - Paid Partner Content
3 Key Factors to Look Out for in Biogen's Q1 Results
Apr 24 / Zacks.com - Paid Partner Content
S&P 500, Dow Hold Slight Gains as Positive Earnings Counter Oil Slump
12:10pm / TheStreet.com - Paid Partner Content
Douglas Lane & Associates, LLC Buys Morgan Stanley, IAC/InterActiveCorp, Lowe's, Sell...
Apr 21 / GuruFocus News - Paid Partner Content
Bristol-Myers (BMY) Beats on Q1 Earnings, Ups 2017 View
11:35am / Zacks.com - Paid Partner Content
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL
Apr 21 / Zacks.com - Paid Partner Content
A Trio of Stocks Up on Nice Results
10:16am / TheStreet.com - Paid Partner Content
Is J&J's Pharma Sales Slowdown a Warning for Other Players?
Apr 19 / Zacks.com - Paid Partner Content
Stocks Turn Mixed in Face of Crude Oil Slump
9:40am / TheStreet.com - Paid Partner Content
Investors bet on Incyte drug success
Apr 19 / FT.com - Paid Partner Content
Stock Futures Higher as Positive Earnings Offset Weaker Durable Goods Orders
7:56am / TheStreet.com - Paid Partner Content
Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion
Apr 18 / Zacks.com - Paid Partner Content
Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports
7:49am / TheStreet.com - Paid Partner Content
Bristol-Myers and Nordic Ink Biomarker Collaboration Deal
Apr 18 / Zacks.com - Paid Partner Content
Market Recon: The Tax Reform Is Just Ordinary Negotiation on Steroids
6:47am / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe's, Bristol-Myers and Priceli...
Apr 18 / Zacks.com - Paid Partner Content
Woodford-backed Allied Minds launches review as losses widen
6:27am / FT.com - Paid Partner Content
Top Research Reports for Alphabet, Amgen & Lowe's
Apr 17 / Zacks.com - Paid Partner Content
Trump targets NAFTA; Tech earnings; U.S. tax plan
4:53am / CNNMoney.com
5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates
Apr 17 / Zacks.com - Paid Partner Content
Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY
Apr 26 / Zacks.com - Paid Partner Content
Biogen to License Alzheimer Candidate from Bristol-Myers
Apr 17 / Zacks.com - Paid Partner Content
Exelixis (EXEL) Q1 Earnings: Will the Stock Disappoint?
Apr 25 / Zacks.com - Paid Partner Content
Activist Jana builds near 9% stake in Whole Foods
Apr 10 / FT.com - Paid Partner Content
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?
Apr 25 / Zacks.com - Paid Partner Content
Merck's Keytruda cancer drug records sales surge
Apr 03 / FT.com - Paid Partner Content
Headinvest, Llc Buys iShares Core S&P Small-Cap, Procter & Gamble Co, Exxon Mobil, .....
Apr 25 / GuruFocus News - Paid Partner Content